Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Journal of Virology|November 1, 2016
A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency VirusShengwen Xiong, Pedro Borrego, Xiaohui Ding, et al.Plos One|October 5, 2011
Origin and epidemiological history of HIV-1 CRF14_BGInês Bártolo, Ana B Abecasis, Pedro Borrego, et al.AIDS Research and Human Retroviruses|September 10, 2011
Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde IslandsVânia Oliveira, Inês Bártolo, Pedro Borrego, et al.International Journal of Molecular Sciences|May 27, 2023
An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 IsolatesNuno Taveira, Inês Figueiredo, Rita Calado, et al.Journal of Virology|May 14, 2010
HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patientsHelena Skar, Pedro Borrego, Timothy C Wallstrom, et al.AIDS (London, England)|October 14, 2017
Potency of HIV-2-specific antibodies increase in direct association with loss of memory B cellsCheila Rocha, Joana Duarte, Pedro Borrego, et al.Sleep & Breathing = Schlaf & Atmung|January 19, 2018
Diagnosis of sleep apnea in patients with stable chronic heart failure using a portable sleep test diagnostic deviceInês Araújo, Filipa Marques, Sandra André, et al.Retrovirology|September 10, 2008
The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patientsPedro Borrego, José Maria Marcelino, Cheila Rocha, et al.AIDS (London, England)|November 5, 2008
Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progressionJosé Maria Marcelino, Charlotta Nilsson, Helena Barroso, et al.AIDS (London, England)|November 16, 2012
Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropismJosé M Marcelino, Pedro Borrego, Charlotta Nilsson, et al.Pageof 4